Clinical Oncology Articles & Analysis
18 articles found
The development of miRNA-based therapies has garnered significant interest, with some products currently in clinical trials. Beyond oncology, miRNA mimics have potential applications in treating various conditions, including cardiovascular diseases, metabolic disorders, and neurodegenerative diseases. By targeting specific pathways involved in disease ...
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. However, the success and general applicability of these treatments heavily depend on the diversity of the participants involved¹?³. This blog explores the importance of achieving data diversity in clinical trials to enhance clinical trial results and ...
Only 20% of patients with ovarian HGSC will be long-term survivors, but no current clinical data can accurately predict which patient will be a short- or long-term survivor. ...
The following patient case demonstrates the application of Adaptiiv’s technology used in clinical radiation oncology through the design and fabrication of customized bolus to improve the efficacy of treating complex target volumes with electron beams. ...
Navigating Cancer, Chief Clinical & Strategy Officer, Dr. Amila Patel, PharmD, BCOP, recently presented data on key findings from a recent abstract with Duke Health revealing racial disparities among head and neck cancer populations at the 2022 American Society of Clinical Oncology conference. ...
Recognizing the need to provide additional patient support, many oncology clinics utilize care navigation nurses and have initiated care management programs such as Principal Care Management (PCM) and Chronic Care Management (CCM). ...
Some companies are analyzing real-world data to create “virtual patients” to help inform selection for clinical trials, while others are using AI to optimize the design of new biologics. ...
The results was published in the Journal of Clinical Oncology. The study, also known as S1800A, was conducted as part of Lung-MAP, the first lung cancer precision medicine trial supported by the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), and conducted at NCI’s National Clinical Trials Network ...
Just days before the sunset of the CMS Oncology Care Model, CMS announced its new Enhancing Oncology Model (EOM), the new value-based care oncology payment model. Rolled out as part of the Biden-Harris Administration’s Cancer Moonshot, the goal of EOM is to improve the experience of cancer patients, while advancing health equity and ...
Worldwide, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer deaths in women, with over 650,000 deaths in 2020.1,2 Human epidermal growth factor receptor 2 (HER2)-targeted agents have improved outcomes in HER2-positive breast cancer, but most patients in first-line therapy do not respond to current therapies, eventually relapse or develop ...
Navigating Cancer in collaboration with Texas Oncology executes large-scale patient engagement study revealing high digital health solution engagement while demonstrating the opportunity to increase support for diverse patient populations. ...
Ethan Basch is Physician-in-Chief of the North Carolina Cancer Hospital and Chief of Oncology at the University of North Carolina (UNC), where he is a Distinguished Professor in Medical Oncology and Professor of Health Policy & Management. Debra Patt, MD, Ph.D., MBA – A community oncology leader, clinical informatics ...
The digital pathology software company PathPresenter (Montville, New Jersey) and the precision oncology platform firm 4D Path have entered into a partnership that could improve the diagnostic accuracy of breast tumor profiling. PathPresenter has developed a digital workflow tool for clinicians, pathologists and pharma companies to aggregate medical data. ...
Dr. Kandace P. McGuire shares how 3D tomosynthesis assisted her during two cases (The Case of the Missing Magseed & Imaging a Bracketed Lesion). In addition, Dr. McGuire discusses how she evaluated the specimens in multiple ways using KUBTEC’s MOZART ...
In the developed world, 1 in 4 people die from cancer or cancer-related disease, and cancer accounts for 13% of deaths globally. Oncology is the fastest growing therapeutic area by revenue and number of clinical trials. ...
Professor Eduard Vrdoljak, Department of Oncology, Clinical Hospital Centre Split, and the University of Split, Croatia and Lead Author on the paper said: “I am extremely worried. ...
The study, funded by GRACE, the Gynae-oncology Research and Clinical Excellence charity, also reported the treatment resulted in improved quality of life and overall survival benefits. It was conducted by Dr Kavitha Madhuri, a Senior Fellow in Gynaecological Oncology at Royal Surrey. The provisional results also suggest dramatic savings in ...
The goal of this IV edition of Villavaquerín’s Charity March is to collect funds to the Department of Paediatric Oncology of the Clinical University Hospital of Valladolid. The march is planned on the 2nd of September at 18:00 and the minimum inscription is 5 € that going to be destined to provide resources to this department. ...